𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM

✍ Scribed by Kartzinel, Ronald; Teychenne, Paul; Gillespie, MarjorieM.; Perlow, Mark; Gielen, AndreaC.; Sadowsky, DorisA.; Calne, DonaldB.


Book ID
122024802
Publisher
The Lancet
Year
1976
Tongue
English
Weight
516 KB
Volume
308
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Initiating levodopa/carbidopa therapy wi
✍ Fabrizio Stocchi; Olivier Rascol; Karl Kieburtz; Werner Poewe; Joseph Jankovic; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract ## Objective L‐dopa is the most widely used and most effective therapy for Parkinson disease (PD), but chronic treatment is associated with motor complications in the majority of patients. It has been hypothesized that providing more continuous delivery of L‐dopa to the brain would red